Antiviral Drugs: From Basic Discovery Through Clinical by Wieslaw M. Kazmierski

By Wieslaw M. Kazmierski

This e-book specializes in new small molecule techniques to wrestle viral infections. The chapters describe the invention and improvement from bench in the course of the hospital of rather recently-approved antiviral medicinal drugs and compounds in complicated scientific improvement. geared up through a virulent disease (such as HIV, HCV, RSV, influenza, HBV and CMV) and written by means of best educational and commercial professionals within the box, the ebook presents a distinct chance to review, comprehend and observe discovery and improvement rules and studying with no the necessity for someone to investigate, examine and synthesize all titanic sourcing references.  issues exhibit demanding situations and suggestions of concerns encountered, offering tremendous adventure gathered over decades of analysis that may be really beneficial to easy and bench scientists in addition to clinicians as they proceed learning and constructing new medicinal drugs and remedies.

Show description

Read or Download Antiviral Drugs: From Basic Discovery Through Clinical Trials PDF

Best pharmacology books

Brain Disabling Treatments in Psychiatry: Drugs, Electroshock, and the Psychopharmaceutical Complex

Well known psychologist Peter Breggin files how psychiatric medicinal drugs and electroshock disable the mind. He provides the most recent medical details on strength mind disorder and hazardous behavioral abnormalities produced through the main typical medications together with Prozac, Xanax, Halcion, Ritalin, and lithium.

Viral Membrane Proteins: Structure, Function, and Drug Design (Protein Reviews)

In Viral Membrane Proteins: constitution, functionality, and Drug layout, Wolfgang Fischer summarizes the present structural and useful wisdom of membrane proteins encoded by means of viruses. moreover, participants to the e-book deal with questions on proteins as strength drug objectives. the variety of knowledge lined comprises sign proteins, ion channels, and fusion proteins.

The Pharmacology of Monoclonal Antibodies

It's been nearly twenty years because the discovery through Kohler and Milstein of the know-how to supply monoclonal antibodies (MAbs), a discovery that promised innovative adjustments in study, medical prognosis and human treatment. From contemporary point of view, it really is reasonable to finish that this promise has been discovered in components of the 3.

Therapeutic Protein Drug Products. Practical Approaches to Formulation in the Laboratory, Manufacturing, and the Clinic

Healing protein drug items offers a entire review of healing protein drug items, with an emphasis on formula starting within the laboratory, by means of production and management within the medical institution. an inventory of many advertisement healing drug items are defined and comprise the product identify, dosages, lively focus, buffer, excipients, Ph, box kind and path of management.

Extra info for Antiviral Drugs: From Basic Discovery Through Clinical Trials

Example text

Response rates of plasma HIV1 RNA < 400 copies at week 48 were 86% and 85% on the boosted atazanavir and unboosted atazanavir regimens. There were 3 and 10 patients with virologic failure in the boosted atazanavir and unboosted atazanavir groups, respectively. Plasma lipid elevations were low with both regimens. At 96 weeks, discontinuation rates were similar in both arms, but the response rates were slightly higher in the boosted atazanavir arm, with fewer virological failures than in the unboosted atazanavir arm.

2008, 47, 161–167. ; et al. Once-daily atazanavir/ritonavir vs. twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for the management of anti-retroviral-naive HIV-1 infected patients. Lancet 2008, 372, 646–655.

Morgan, K. T. A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments. Cancer Lett. 1995, 93, 129–146. [15] Gold, L. ; Slone, T. ; Stern, B. ; Bernstein, L. Comparison of target organs of carcinogenicity for P1: TIX/XYZ JWBS061-01 P2: ABC JWBS061-Kazmierski 16 [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] May 24, 2011 16:56 Printer Name: Yet to Come DISCOVERY AND DEVELOPMENT OF ATAZANAVIR mutagenic and non-mutagenic chemicals. Mutat.

Download PDF sample

Rated 4.11 of 5 – based on 4 votes